{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:20:34Z","timestamp":1778077234545,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bmc.2023.117156","type":"journal-article","created":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T09:42:04Z","timestamp":1673170924000},"page":"117156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agents"],"prefix":"10.1016","volume":"79","author":[{"given":"Jichao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E-Hu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117156_b0005","article-title":"Research advances on anti-cancer natural products","volume":"12","author":"Guo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2023.117156_b0010","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1021\/acs.chemrev.8b00504","article-title":"Structural simplification of natural products","volume":"119","author":"Wang","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2023.117156_b0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.fitote.2015.04.012","article-title":"Insights into drug discovery from natural products through structural modification","volume":"103","author":"Chen","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmc.2023.117156_b0020","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2023.117156_b0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.apsb.2016.06.003","article-title":"The modification of natural products for medical use","volume":"7","author":"Guo","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2023.117156_b0030","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","article-title":"Biological properties and clinical applications of berberine","volume":"14","author":"Song","year":"2020","journal-title":"Front Med -Prc"},{"key":"10.1016\/j.bmc.2023.117156_b0035","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bmc.2023.117156_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116598","article-title":"Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice","volume":"55","author":"Yang","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0045","article-title":"Current evidence and future directions of berberine intervention in depression","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2023.117156_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.631100","article-title":"A new therapeutic candidate for cardiovascular diseases: berberine","volume":"12","author":"Cai","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2023.117156_b0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/toxins12110713","article-title":"Biological activity of berberine-A summary update","volume":"21","author":"Och","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.bmc.2023.117156_b0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12885-019-5791-1","article-title":"Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bmc.2023.117156_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173655","article-title":"The pharmacological activity of berberine, a review for liver protection","volume":"890","author":"Zhou","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2023.117156_b0070","doi-asserted-by":"crossref","first-page":"e21416","DOI":"10.1371\/journal.pone.0021416","article-title":"Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117156_b0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3892\/mmr.2013.1506","article-title":"Berberine induces selective apoptosis through the AMPK-mediated mitochondrial\/caspase pathway in hepatocellular carcinoma","volume":"8","author":"Yang","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bmc.2023.117156_b0080","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/ptr.7032","article-title":"Berberine-A potent chemosensitizer and chemoprotector to conventional cancer therapies","volume":"35","author":"Devarajan","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.bmc.2023.117156_b0085","first-page":"1525","article-title":"Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib","volume":"40","author":"Huang","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmc.2023.117156_b0090","article-title":"Berberine sensitizes human hepatoma cells to regorafenib via modulating expression of circular RNAs","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2023.117156_b0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmc.2023.117156_b0100","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s11426-014-5235-3","article-title":"DNA G-quadruplex and its potential as anticancer drug target","volume":"57","author":"Onel","year":"2014","journal-title":"Sci China Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-021-01328-4","article-title":"G-quadruplexes: A promising target for cancer therapy","volume":"20","author":"Kosiol","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bmc.2023.117156_b0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2023.117156_b0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/acs.jmedchem.0c01145","article-title":"Recent update on targeting c-MYC G-quadruplexes by small molecules for anticancer therapeutics","volume":"64","author":"Chaudhuri","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/molecules26040841","article-title":"Recent developments in small-molecule ligands of medicinal relevance for harnessing the anticancer potential of G-quadruplexes","volume":"26","author":"Savva","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117156_b0125","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/593408","article-title":"Polymorphic nucleic acid binding of bioactive isoquinoline alkaloids and their role in cancer","volume":"2010","author":"Maiti","year":"2010","journal-title":"J Nucleic Acids"},{"key":"10.1016\/j.bmc.2023.117156_b0130","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1021\/acs.jmedchem.1c01508","article-title":"Berberine molecular recognition of the parallel MYC G-quadruplex in solution","volume":"64","author":"Dickerhoff","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0135","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/molecules23061423","article-title":"Natural aromatic compounds as scaffolds to develop selective G-quadruplex ligands: from previously reported berberine derivatives to new palmatine analogues","volume":"23","author":"Franceschin","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117156_b0140","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.ejmech.2011.02.020","article-title":"Quinolino-benzo-[5,6]-dihydroisoquindolium compounds derived from berberine: A new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene","volume":"44","author":"Ma","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0145","doi-asserted-by":"crossref","first-page":"e102711","DOI":"10.1371\/journal.pone.0102711","article-title":"Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues","volume":"9","author":"Biffi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117156_b0150","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1080\/14756366.2022.2118268","article-title":"Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents","volume":"37","author":"Chen","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174586","article-title":"Tanshinone IIA derivatives induced S-phase arrest through stabilizing c-myc G-quadruplex DNA to regulate ROS-mediated PI3K\/Akt\/mTOR pathway","volume":"912","author":"Wang","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2023.117156_b0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchem.1548","article-title":"Quantitative visualization of DNA G-quadruplex structures in human cells","volume":"5","author":"Biffi","year":"2013","journal-title":"Nat Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gde.2013.10.012","article-title":"Existence and consequences of G-quadruplex structures in DNA","volume":"25","author":"Murat","year":"2014","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.bmc.2023.117156_b0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/1381612003400948","article-title":"Cell cycle molecular targets in novel anticancer drug discovery","volume":"6","author":"Buolamwini","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2023.117156_b0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejmech.2017.12.092","article-title":"5-Bromo-oxoisoaporphine platinum(II) complexes exhibit tumor cell cytotoxcicity via inhibition of telomerase activity and disruption of c-myc G-quadruplex DNA and mitochondrial functions","volume":"145","author":"Wei","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jinorgbio.2016.01.001","article-title":"Dinuclear ruthenium complexes display loop isomer selectivity to c-MYC DNA G-quadriplex and exhibit anti-tumour activity","volume":"156","author":"Zheng","year":"2016","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmc.2023.117156_b0185","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.jmedchem.7b01615","article-title":"Discovery of novel schizocommunin derivatives as telomeric G-quadruplex ligands that trigger telomere dysfunction and the deoxyribonucleic acid (DNA) damage response","volume":"61","author":"Che","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117156_b0190","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Circu","year":"2010","journal-title":"Free Radical Bio Med"},{"key":"10.1016\/j.bmc.2023.117156_b0195","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10495-017-1424-9","article-title":"Induction of reactive oxygen species: An emerging approach for cancer therapy","volume":"22","author":"Zou","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.bmc.2023.117156_b0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5483\/BMBRep.2008.41.1.011","article-title":"The role of mitochondria in apoptosis","volume":"41","author":"Jeong","year":"2008","journal-title":"BMB Rep"},{"key":"10.1016\/j.bmc.2023.117156_b0205","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.bmc.2023.117156_b0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fonc.2018.00160","article-title":"Phosphoinositide 3-kinase\/Akt signaling and redox metabolism in cancer","volume":"8","author":"Koundouros","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2023.117156_b0215","first-page":"4654","article-title":"Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation","volume":"20","author":"Song","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bmc.2023.117156_b0220","article-title":"Berberine and oligomeric proanthocyanidins exhibit synergistic efficacy through regulation of PI3K-Akt signaling pathway in colorectal cancer","volume":"12","author":"Okuno","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2023.117156_b0225","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.biopha.2017.09.010","article-title":"Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0\/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways","volume":"95","author":"Li","year":"2017","journal-title":"Biomed Pharmacother"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:20:47Z","timestamp":1760836847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":45,"alternative-id":["S0968089623000044"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117156","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117156"}}